Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
BMC Cancer ; 15: 70, 2015 Feb 19.
Article in English | MEDLINE | ID: mdl-25879571

ABSTRACT

BACKGROUND: We previously identified dermicidin (DCD), which encodes a growth and survival factor, as a gene amplified and overexpressed in a subset of breast tumors. Patients with DCD-positive breast cancer have worse prognostic features. We therefore searched for specific molecular signatures in DCD-positive breast carcinomas from patients and representative cell lines. METHODS: DCD expression was evaluated by qRT-PCR, immunohistochemical and immunoblot assays in normal and neoplastic tissues and cell lines. To investigate the role of DCD in breast tumorigenesis, we analyzed the consequences of its downregulation in human breast cancer cell lines using three specific shRNA lentiviral vectors. Genes up- and down-regulated by DCD were identified using Affymetrix microarray and analyzed by MetaCore Platform. RESULTS: We identified DCD splice variant (DCD-SV) that is co-expressed with DCD in primary invasive breast carcinomas and in other tissue types and cell lines. DCD expression in breast tumors from patients with clinical follow up data correlated with high histological grade, HER2 amplification and luminal subtype. We found that loss of DCD expression led to reduced cell proliferation, resistance to apoptosis, and suppressed tumorigenesis in immunodeficient mice. Network analysis of gene expression data revealed perturbed ERBB signaling following DCD shRNA expression including changes in the expression of ERBB receptors and their ligands. CONCLUSIONS: These findings imply that DCD promotes breast tumorigenesis via modulation of ERBB signaling pathways. As ERBB signaling is also important for neural survival, HER2+ breast tumors may highjack DCD's neural survival-promoting functions to promote tumorigenesis.


Subject(s)
Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Dermcidins/genetics , Dermcidins/metabolism , Receptor, ErbB-2/metabolism , Signal Transduction , Alternative Splicing , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacology , Biomarkers , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Cell Line, Tumor , Cluster Analysis , Disease Models, Animal , Female , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Heterografts , Humans , Immunohistochemistry , Receptor, ErbB-2/antagonists & inhibitors , Trastuzumab/administration & dosage , Trastuzumab/pharmacology , Tumor Burden/drug effects
2.
Sci Rep ; 3: 1266, 2013.
Article in English | MEDLINE | ID: mdl-23405280

ABSTRACT

Objectives were to evaluate the role of canonical WNT signaling in development of the preimplantation embryo. Signaling was activated with 2-Amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine (AMBMP) and inhibited with Dickkopf-related protein 1 (DKK1). Treatment of bovine embryos with AMBMP at day 5 after insemination decreased development to the blastocyst stage at day 7 and reduced numbers of trophectoderm and inner cell mass cells. At high concentrations, AMBMP caused disorganization of the inner cell mass. DKK1 blocked actions of AMBMP but did not affect development in the absence of AMBMP. Examination of gene expression in day 6 morulae by microarray revealed expression of 16 WNT genes and other genes involved in WNT signaling; differences in relative expression were confirmed by PCR for 7 genes. In conclusion, the preimplantation embryo possesses a functional WNT signaling system and activation of the canonical pathway can inhibit embryonic development.


Subject(s)
Blastocyst/metabolism , Embryo, Mammalian/cytology , Wnt Proteins/metabolism , Wnt Signaling Pathway/genetics , Animals , Benzodioxoles/chemistry , Benzodioxoles/pharmacology , Blastocyst/cytology , Blastocyst/drug effects , Cattle , Embryo, Mammalian/metabolism , Embryonic Development , Female , Gene Expression Regulation, Developmental/drug effects , Insemination , Intercellular Signaling Peptides and Proteins/chemistry , Intercellular Signaling Peptides and Proteins/metabolism , Pyrimidines/chemistry , Pyrimidines/pharmacology , Wnt Proteins/agonists , Wnt Signaling Pathway/drug effects
3.
Reproduction ; 141(5): 617-24, 2011 May.
Article in English | MEDLINE | ID: mdl-21339286

ABSTRACT

Exposure of bovine conceptuses to colony-stimulating factor 2 (CSF2) from days 5 to 7 of development can increase the percentage of transferred conceptuses that develop to term. The purpose of this experiment was to understand the mechanism by which CSF2 increases embryonic and fetal survival. Conceptuses were produced in vitro in the presence or absence of 10  ng/ml CSF2 from days 5 to 7 after insemination, transferred into cows, and flushed from the uterus at day 15 of pregnancy. There was a tendency (P=0.07) for the proportion of cows with a recovered conceptus to be greater for those receiving a CSF2-treated conceptus (35% for control versus 66% for CSF2). Antiviral activity in uterine flushings, a measure of the amount of interferon-τ (IFNT2) secreted by the conceptus, tended to be greater for cows receiving CSF2-treated conceptuses than for cows receiving control conceptuses. This difference approached significance when only cows with detectable antiviral activity were considered (P=0.07). In addition, CSF2 increased mRNA for IFNT2 (P=0.08) and keratin 18 (P<0.05) in extraembryonic membranes. Among a subset of filamentous conceptuses that were analyzed by microarray hybridization, there was no effect of CSF2 on gene expression in the embryonic disc or extraembryonic membranes. Results suggest that the increase in calving rate caused by CSF2 treatment involves, in part, more extensive development of extraembryonic membranes and capacity of the conceptus to secrete IFNT2 at day 15 of pregnancy.


Subject(s)
Embryo, Mammalian/drug effects , Fertilization in Vitro/veterinary , Gene Expression Regulation, Developmental/drug effects , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Interferon Type I/metabolism , Pregnancy Proteins/metabolism , Adaptor Proteins, Signal Transducing/genetics , Analysis of Variance , Animals , Cattle , Cytopathogenic Effect, Viral/drug effects , Embryo Culture Techniques , Embryo Transfer/veterinary , Embryo, Mammalian/metabolism , Embryonic Development/drug effects , Embryonic Development/genetics , Extraembryonic Membranes/drug effects , Extraembryonic Membranes/metabolism , Female , Gene Expression Profiling/methods , Gestational Age , Interferon Type I/genetics , Keratin-18/genetics , Least-Squares Analysis , Oligonucleotide Array Sequence Analysis , Polymerase Chain Reaction , Pregnancy , Pregnancy Proteins/genetics , RNA, Messenger/metabolism , Recombinant Proteins/pharmacology , Vesiculovirus/pathogenicity , src Homology Domains/genetics
4.
Muscle Nerve ; 42(6): 927-35, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20928906

ABSTRACT

Spaceflight and bed rest (BR) lead to muscle atrophy. This study assessed the effect of essential amino acid (EAA) supplementation and resistance training with decreased energy intake on molecular changes in skeletal muscle after 28-day BR and 14-day recovery. Thirty-one men (31-55 years) subjected to an 8 ± 6% energy deficit were randomized to receive EAA without resistance training (AA, n = 7), or EAA 3 h after (RT, n = 12) or 5 min before (AART, n = 12) resistance training. During BR, myostatin transcript levels increased twofold in the AA group. During recovery, insulin-like growth factor-1 (IGF-1) mRNA increased in all groups, whereas Pax7, MyoD, myogenin, and MRF4 transcripts increased in AA only (all P < 0.05). MAFbx transcripts decreased twofold with AA and RT. Satellite cells did not change during BR or recovery. This suggests that EAA alone is the least protective countermeasure to muscle loss, and several molecular mechanisms are proposed by which exercise attenuates muscle atrophy during BR with energy deficit.


Subject(s)
Amino Acids, Essential/administration & dosage , Bed Rest , Muscle, Skeletal/metabolism , Muscular Atrophy/metabolism , Muscular Atrophy/therapy , Resistance Training , Adult , Amino Acids, Essential/metabolism , Analysis of Variance , Down-Regulation , Humans , Immunohistochemistry , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/metabolism , Male , Middle Aged , Muscular Atrophy/genetics , MyoD Protein/genetics , MyoD Protein/metabolism , Myogenic Regulatory Factors/genetics , Myogenic Regulatory Factors/metabolism , Myogenin/genetics , Myogenin/metabolism , Myostatin/genetics , Myostatin/metabolism , PAX7 Transcription Factor/genetics , PAX7 Transcription Factor/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Up-Regulation
5.
Biochem Biophys Res Commun ; 388(2): 418-21, 2009 Oct 16.
Article in English | MEDLINE | ID: mdl-19665989

ABSTRACT

Apoptosis in the bovine embryo cannot be induced by activators of the extrinsic apoptosis pathway until the 8-16-cell stage. Depolarization of mitochondria with the decoupling agent carbonyl cyanide 3-chlorophenylhydrazone (CCCP) can activate caspase-3 in 2-cell embryos but DNA fragmentation does not occur. Here we hypothesized that the repression of apoptosis is caused by methylation of DNA and deacetylation of histones. To test this hypothesis, we evaluated whether reducing DNA methylation by 5-aza-2'-deoxycytidine (AZA) or inhibition of histone deacetylation by trichostatin-A (TSA) would make 2-cell embryos susceptible to DNA fragmentation caused by CCCP. The percent of blastomeres positive for TUNEL was affected by a treatment x CCCP interaction (P<0.0001). CCCP did not cause a large increase in the percent of cells positive for TUNEL in embryos treated with vehicle but did increase the percent of cells that were TUNEL positive if embryos were pretreated with AZA or TSA. Immunostaining using an antibody against 5-methyl-cytosine antibody revealed that AZA and TSA reduced DNA methylation. In conclusion, disruption of DNA methylation and histone deacetylation removes the block to apoptosis in bovine 2-cell embryos.


Subject(s)
Apoptosis , Blastocyst/physiology , Cytosine/metabolism , DNA Methylation , Histones/metabolism , 5-Methylcytosine/analysis , 5-Methylcytosine/metabolism , Animals , Apoptosis/drug effects , Azacitidine/analogs & derivatives , Blastocyst/drug effects , Blastocyst/metabolism , Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology , Cattle , DNA Fragmentation , Decitabine , Histone Deacetylase Inhibitors , Histone Deacetylases/metabolism , Hydroxamic Acids/pharmacology
6.
Am J Physiol Regul Integr Comp Physiol ; 290(4): R1080-6, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16306159

ABSTRACT

In this study, we investigated the effect of age on the association of eukaryotic initiation factor 4E (eIF4E) with eukaryotic initiation factor 4G (eIF4G), as well as the activity of its binding protein (4E-BP1) and the activity of glycogen synthase kinase-3 (GSK-3) after a single bout of rat hindlimb muscle contractile activity elicited by high-frequency electrical stimulation (HFES) of the sciatic nerve. Tibialis anterior (TA) and plantaris (Pla) muscles from adult (Y; 6 mo old) and aged (O; 30 mo old) Fischer 344 x Brown Norway rats were collected immediately or 6 h after HFES. eIF4E-eIF4G association was elevated at 6 h of recovery in TA (1.9 +/- 0.2-fold, P < 0.05) and immediately and 6 h after exercise in Pla (2.1 +/- 0.3- and 2.1 +/- 0.7-fold, P < 0.05) in Y rats. No significant increase was observed in O rats. An increase in 4E-BP1 phosphorylation was observed only 6 h after HFES in TA (5.0 +/- 2.0-fold, P < 0.05) in Y rats. Phosphorylation of GSK-3alpha was increased immediately and 6 h after contraction in TA (1.6 +/- 0.3- and 4.1 +/- 0.8-fold, P < 0.05) and Pla (1.7 +/- 0.2- and 2.1 +/- 0.4-fold, P < 0.05) in Y rats and remained unaffected in O rats. Phosphorylation of GSK-3beta was observed only immediately after HFES in TA (1.5 +/- 0.2-fold, P < 0.05) in Y rats. Overall, eIF4E-eIF4G association and phosphorylation of 4E-BP1 and GSK-3 are increased after HFES in adult, but not in aged, animals. These observations suggest that the anabolic response to muscle stimulation is attenuated with aging and may contribute to the limited capacity of hypertrophy in aged animals.


Subject(s)
Aging , Muscle Contraction/physiology , Muscle, Skeletal/physiology , Proto-Oncogene Proteins c-akt/metabolism , Animals , Carrier Proteins/metabolism , Eukaryotic Initiation Factor-4E/metabolism , Eukaryotic Initiation Factor-4G/metabolism , Glycogen Synthase Kinase 3/metabolism , Glycogen Synthase Kinase 3 beta , Humans , Intracellular Signaling Peptides and Proteins , Male , Muscle, Skeletal/anatomy & histology , Organ Size , Phosphoproteins/metabolism , Phosphorylation , Protein Kinases/metabolism , Rats , Rats, Inbred F344 , Signal Transduction , TOR Serine-Threonine Kinases
7.
Theriogenology ; 63(4): 1014-25, 2005 Mar 01.
Article in English | MEDLINE | ID: mdl-15710189

ABSTRACT

The presence of prorenin, renin, angiotensinogen, angiotensin-converting enzyme, angiotensin II (Ang II) and Ang II receptors in the ovary is suggestive of a functional ovarian renin-angiotensin system (RAS). In cattle, the expression of Ang II is greatest in large follicles, suggesting that it is important during follicular growth and maturation. The present study was designed to investigate the role of Ang II in bovine oocyte nuclear maturation. Bovine cumulus-oocyte complexes (COCs) were cultured with or without follicular cells and Ang II or saralasin (Ang II antagonist). In the absence of follicular cells, Ang II at 0, 10(-11), 10(-9) and 10(-7) M did not affect the percentage of oocytes reaching the germinal vesicle breakdown (GVBD), metaphase I (MI) and metaphase II (MII) stage after 7-h (41.3 +/- 4.3, 35.3 +/- 4.0, 31.3 +/- 9.7, 38.7 +/- 8.6), 12-h (31.6 +/- 7.0, 34.7 +/- 6.1, 31.7 +/- 5.3, 28.9 +/- 9.1; mean +/- S.E.M.) and 18-h (44.9 +/- 7.3, 58.4 +/- 8.4, 53.1 +/- 7.4, 44.9 +/- 7.3) of culture, respectively. Similarly, saralasin at 0, 10(-11), 10(-9) and 10(-7) M did not affect the percentage of oocytes reaching MII stage after 18-h of culture (37.6 +/- 7.4, 34.4 +/- 7.7, 30.0 +/- 10.8 and 31.2 +/- 5.1, respectively). The theca cells (MII = 22.9%) or medium conditioned with follicular cells (GV = 65.5%, MI = 23.6%) inhibited oocyte maturation; however, theca cells (MII = 35.5 +/- 4.9; P < 0.05) or medium conditioned with follicular cells (GV = 34.6%, MI = 52.7%; P < 0.01) were not able to inhibit nuclear maturation when Ang II (10(-11) M) was present in the culture system. Theca cells remained viable during the culture period when Ang II was present. Therefore, results supported the idea of a role of Ang II in blocking the inhibitory effect of theca cells on nuclear maturation of bovine oocytes.


Subject(s)
Angiotensin II/pharmacology , Cattle , Cell Nucleus/drug effects , Cell Nucleus/physiology , Oocytes/ultrastructure , Theca Cells/physiology , Angiotensin II/antagonists & inhibitors , Animals , Cell Survival , Cells, Cultured , Culture Media, Conditioned , Female , Metaphase/drug effects , Ovarian Follicle/cytology , Ovarian Follicle/physiology , Saralasin/pharmacology
8.
Reprod Biol Endocrinol ; 1: 15, 2003 Feb 11.
Article in English | MEDLINE | ID: mdl-12657159

ABSTRACT

We recently demonstrated that caspase-3 is important for apoptosis during spontaneous involution of the corpus luteum (CL). These studies tested if prostaglandin F2alpha (PGF2alpha) or FAS regulated luteal regression, utilize a caspase-3 dependent pathway to execute luteal cell apoptosis, and if the two receptors work via independent or potentially shared intracellular signaling components/pathways to activate caspase-3. Wild-type (WT) or caspase-3 deficient female mice, 25-26 days old, were given 10 IU equine chorionic gonadotropin (eCG) intraperitoneally (IP) followed by 10 IU human chorionic gonadotropin (hCG) IP 46 h later to synchronize ovulation. The animals were then injected with IgG (2 micrograms, i.v.), the FAS-activating antibody Jo2 (2 micrograms, i.v.), or PGF2alpha (10 micrograms, i.p.) at 24 or 48 h post-ovulation. Ovaries from each group were collected 8 h later for assessment of active caspase-3 enzyme and apoptosis (measured by the TUNEL assay) in the CL. Regardless of genotype or treatment, CL in ovaries collected from mice injected 24 h after ovulation showed no evidence of active caspase-3 or apoptosis. However, PGF2alpha or Jo2 at 48 h post-ovulation and collected 8 h later induced caspase-3 activation in 13.2 +/- 1.8% and 13.7 +/- 2.2 % of the cells, respectively and resulted in 16.35 +/- 0.7% (PGF2alpha) and 14.3 PlusMinus; 2.5% TUNEL-positive cells when compared to 1.48 +/- 0.8% of cells CL in IgG treated controls. In contrast, CL in ovaries collected from caspase-3 deficient mice whether treated with PGF2alpha, Jo2, or control IgG at 48 h post-ovulation showed little evidence of active caspase-3 or apoptosis. CL of WT mice treated with Jo2 at 48 h post-ovulation had an 8-fold increase in the activity of caspase-8, an activator of caspase-3 that is coupled to the FAS death receptor. Somewhat unexpectedly, however, treatment of WT mice with PGF2alpha at 48 h post-ovulation resulted in a 22-fold increase in caspase-8 activity in the CL, despite the fact that the receptor for PGF2alpha has not been shown to be directly coupled to caspase-8 recruitment and activation. We hypothesize that PGF2alpha initiates luteolysis in vivo, at least in part, by increasing the bioactivity or bioavailability of cytokines, such as FasL and that multiple endocrine factors work in concert to activate caspase-3-driven apoptosis during luteolysis.


Subject(s)
Apoptosis/drug effects , Caspases/physiology , Corpus Luteum/drug effects , Dinoprost/pharmacology , Luteolysis/drug effects , fas Receptor/pharmacology , Animals , Animals, Congenic , Apoptosis/physiology , Caspase 3 , Caspase 8 , Caspases/deficiency , Caspases/genetics , Corpus Luteum/cytology , Corpus Luteum/enzymology , Dinoprost/antagonists & inhibitors , Dinoprost/immunology , Enzyme Activation/drug effects , Female , Luteolysis/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Progesterone/blood , Signal Transduction/drug effects , fas Receptor/immunology
9.
Endocrinology ; 143(4): 1495-501, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11897708

ABSTRACT

Because caspase-3 is considered a primary executioner of apoptosis and has been implicated as a mediator of luteal regression, we hypothesized that corpora lutea (CL) derived from caspase-3 null mice would exhibit a delayed onset of apoptosis during luteal regression, when compared with CL derived from wild-type (WT) mice. To test this hypothesis, ovulation was synchronized in immature (postpartum d 24-27) WT and caspase-3-deficient female littermates by exogenous gonadotropins. Individual CL were isolated by manual dissection, 30 h after ovulation, and placed in organ culture dishes in the absence of serum and growth factors. At the time of isolation (0 h) and after 24, 48, and 72 h in culture, the CL were removed and assessed for the presence of processed (active) caspase-3 enzyme and for apoptosis by multiple criteria. There was no evidence of active caspase-3 enzyme or apoptosis in either WT or caspase-3-deficient CL before culture. However, CL derived from the WT mice exhibited a time-dependent increase in the level of active caspase-3 and apoptosis during culture. By comparison, CL derived from caspase-3-deficient mice, cultured in parallel, failed to exhibit any detectable active caspase-3 and showed attenuated rates of apoptosis. To extend these findings derived from ex vivo culture experiments, ovaries were collected from WT and caspase-3 null female littermates at 2, 4, or 6 d post ovulation, and the occurrence of apoptosis within the CL was analyzed. Whereas ovaries of WT mice had only residual luteal tissue at d 6 post ovulation, ovaries collected from caspase-3-deficient mice retained many CL, at d 6 post ovulation, that were similar in size to those observed in the early luteal phase of WT mice. Importantly, there was no dramatic increase in apoptosis in CL of caspase-3-deficient mice at any time point examined post ovulation, indicating that the involution process had indeed been delayed. In contrast, the levels of progesterone declined regardless of genotype. These data provide the first direct evidence that caspase-3 is functionally required for apoptosis to proceed normally during luteal regression. However, caspase-3 is not a direct mediator of the decrease in steroidogenesis associated with luteolysis.


Subject(s)
Apoptosis/physiology , Caspases/physiology , Corpus Luteum/physiology , Ovary/physiology , Animals , Caspase 3 , Caspases/genetics , Corpus Luteum/cytology , Corpus Luteum/enzymology , DNA/biosynthesis , DNA/genetics , DNA/isolation & purification , DNA Fragmentation/physiology , Electrophoresis, Polyacrylamide Gel , Female , Immunohistochemistry , In Situ Nick-End Labeling , Mice , Mice, Knockout , Organ Culture Techniques , Ovary/cytology , Ovary/enzymology , Ovulation/physiology , Progesterone/metabolism , Rats
10.
Braz. j. morphol. sci ; 13(2): 177-80, jul.-dez. 1996. ilus
Article in English | LILACS | ID: lil-263427

ABSTRACT

Among the anatomical techniques developed to obtain dry material, the cryodehydration is an important procedure, since it is very helpful in pratical classes. By alternating freezing and thawing (FT) sctions, the cell destruction simplifies fluids release, obtaining material with some advantages such as: form keeping, loss of weight, no need for fixer (no mucosal irritation) and a low cost technique.


Subject(s)
Animals , Desiccation/methods , In Vitro Techniques , Organ Preservation/methods , Cryopreservation , Freezing , Low Cost Technology
SELECTION OF CITATIONS
SEARCH DETAIL
...